Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
67.06
1.52 (2.32%)
At close: Aug 15, 2025, 1:20 PM
13F Institute Ownership
Total Institutes of 555 in Halozyme Therapeutics expanded their positions with an increase of 34 investors compared to the previous quarter. A reduction of 2.1M shares, as total invested capital grew by $1.82B with ownership percentage increasing from 97.54% to 98.71%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.354
0.35
Call Flow 319,700
74%
Put Flow 113,100
26%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Blackrock, Inc. | 13.87% | 17.09M | -2.7% | 1.09B | 0.02% | May 02, 2025 |
| Vanguard Group Inc | 10.41% | 12.83M | -3.39% | 818.78M | 0.01% | May 09, 2025 |
| State Street Corp | 4.91% | 6.05M | -15.75% | 386.24M | 0.02% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.